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Plasma cell neoplasms occasionally involve the joints, including the elbows, typically as plasmacytomas. e elbow is an unusual but reported location of plasmacytomas. 3, 4 A case of multiple myeloma and amyloid light-chain (AL) amyloidosis has been reported, with manifestations including pseudomyopathy, bone marrow plasmacytosis, and bilateral trochanteric bursitis. 5 Bursitis is de ned as in ammation of the synovial-uid-containing sacs that lubricate joints. e olecranon bursa is commonly a ected. Etiologies include infection, in ammatory disease, trauma, and malignancy. Furthermore, there is an association between bursitis and immunosuppression. 6, 7 e most common modes of therapy used to treat bursitis are nonsteroidal anti-in ammatory drugs, corticosteroid injections, and surgical management.
Trochanteric bursitis has been attributed to multiple myeloma in one previous case report, but we are not aware of any previous cases of olecranon bursitis caused by multiple myeloma. Here, we present the case of a 46-year-old man with heavily pretreated multiple myeloma and amyloidosis who developed left olecranon bursitis contemporaneously with disease relapse; ow cytometric analysis of the bursal uid demonstrated an abnormal plasma cell population, establishing the etiology.
Case presentation and summary
A 46-year-old man with a longstanding history of multiple myeloma developed swelling of the left elbow that was initially painless in September 2016. He had been diagnosed with IgA kappa multiple myeloma and AL deposition in 2011. Over the course of his disease, he was treated with the following sequence of therapies: cyclophosphamide, bortezomib, and dexamethasone, followed by melphalanconditioned autologous peripheral blood stem cell transplant; lenalidomide and dexamethasone; car lzomib and dexamethasone; pomalidomide, bortezomib, and dexamethasone; and bortezomib, lenalidomide, dexamethasone, doxorubicin, cyclophosphamide, and etoposide, followed by second melphalan-conditioned autologous peripheral blood stem cell transplant. In addition to treatment with numerous novel and chemotherapeutic agents, his disease course was notable for amyloid deposition in the liver, bone marrow, and kidneys, which resulted in dialysis dependence.
After the second autologous transplant, he achieved a very good partial response and experienced about 9 months of remission, after which laboratory evaluation indicated recurrence of IgA kappa monoclonal protein and free kappa light-chains, which increased slowly over several months without focal symptoms, cytopenias, or decline in organ function (Figure 1 ).
Twelve months after his second transplant, he presented in September 2016 with 4 weeks of left elbow swelling, with the appearance suggesting a uid collection over the left olecranon process (Figure 2 ). e uid collection was not painful unless bumped or pushed. e maximum pain level was 1-2 on a scale of 0-10. His daughter drained the uid collection on 2 occasions, but it reaccumulated over 2 to 3 days. He reported no fevers, chills, or sweats. He did not Physical examination of the left elbow demonstrated a ballotable uid collection associated with the olecranon, with no associated warmth, tenderness, or erythema. Bursal uid was sampled, yielding orange-colored serous uid with bland characteristics (Figure 3 ). Microbiologic studies were negative (Table 1) . We did not suspect a malignant cause initially.
e uid collection persisted despite treatment with nonsteroidal anti-in ammatory drugs and serial drainage procedures approximately twice per week. It became more erythematous and uncomfortable. We repeated diagnostic sampling at 13 months post-transplant. Cytospin revealed scant plasma cells. A multiparametric 8-color ow cytometric analysis was performed on the bursal uid. It demonstrated the presence of a small abnormal population of plasma cells (0.04%).
e abnormal plasma cells showed expression of CD138 and bright CD38 with aberrant expression of CD56, dim CD45, and loss of CD19, CD81 and CD27. ey did not express CD117 or CD20 (Figure 4) .
Because of the patient's discomfort and his history of multidrug-refractory multiple myeloma, we obtained computed tomography imaging of the axial and appendicular skeleton, which demonstrated di use small lytic lesions, none larger than 3 mm, including the left elbow joint. e patient began systemic treatment with ixazomib, pomalidomide, and dexamethasone and then received radiation therapy of 20 Gy in 4 fractions to the left olecranon area. e bursal uid collection remained stable in size but required periodic, though less frequent, drainage procedures. Unfortunately, the patient only tolerated 2 cycles of systemic therapy before experiencing hypercalcemia, exacerbation of hepatic amyloidosis, and a decline in performance status. He died 17 months after the transplant.
Discussion
Our patient experienced left olecranon bursitis simultaneously with relapse of multiple myeloma and AL amyloidosis. Evaluation for infectious causes was negative, and the bursal uid did not have strongly in ammatory characteristics. Furthermore, a small plasma cell population was isolated from the uid. Imaging did not reveal an underlying dominant lytic lesion. Although we do not have direct pathologic con rmation, the clinical scenario and ow cytometry ndings support our interpretation that the patient's bursitis was caused by or at least related to underlying multiple myeloma. While reactive plasma cells are also CD38 positive and CD138 positive, they maintain the expression of CD19 and CD45 without aberrant expression of CD56 or CD117 and do not show loss of expression of CD81 or CD27. In this situation, we suspect that either a plasmacytoma involving the soft tissue of the bursa or amyloid in ltration of the synovium may have occurred. Anti-myeloma therapies and radiation therapy did not result in control of the Case Report bursitis, though it should be noted that the patient's highly refractory disease progressed despite treatment with a combination of later-generation immunomodulatory imide and proteasome inhibitor therapies.
Cases of malignant bursitis have been reported several times in the literature, though nearly all of the instances involved connective tissue or metastatic tumors. Tumor histologies include osteochondroma, 8, 9 malignant brous histiocytoma, 10 synovial sarcoma, 11 and metastatic breast cancer. 12 Hematologic malignancies are more rare causes of bursitis; our literature search identi ed a report of 2 cases of nonHodgkin lymphoma mimicking rheumatoid arthritis. e joints were the knee and elbow. Synovial uid from one case was clear and yellow, with leukocytosis with a neutrophilic predominance (similar to our case). In both cases, pathology con rmed lymphomatous in ltration of the synovium. 13 Notably, we identi ed a case of a previously healthy 35-yearold woman with bilateral trochanteric bursitis. Biopsy of tissue from the right trochanteric bursa demonstrated positive birefringence, diagnostic of AL amyloidosis. e patient also had a biclonal paraprotein accompanied by calvarial lytic lesions. She was treated with a corticosteroid pulse and bisphosphonates, followed by autologous hematopoietic stem cell transplant. 5 Our case shares features with the above case, including the relatively young age of the patient and the presence of AL amyloidosis.
Our patient wished to avoid a surgical biopsy procedure, and therefore we utilized ow cytometry of the bursal uid to establish that the etiology of uid collection was consistent with his concurrent relapse of multiple myeloma. We believe that we are reporting the second case of multiple myelomaassociated bursitis and the rst case associated with multiple myeloma relapse; to our knowledge, it is the rst to be diagnosed with the aid of ow cytometry.
Because of our patient's reliance on hemodialysis beginning one year prior to his presentation with olecranon bursitis, we entertain "dialysis elbow" within the di erential diagnosis. Dialysis elbow is a relatively uncommon complication of dialysis, in which patients develop olecranon bursitis on the same side as the hemodialysis access after a prolonged (months to years) duration of hemodialysis. Serositis and mechanical forces are the hypothesized etiologies 14 ; infectious and rheumatologic causes were excluded from the reported cases. Nevertheless, we favor a malignant cause based upon the ow cytometry ndings indicating involvement by immunophenotypically abnormal plasma cells.
Our patient was treated initially with serial drainage and nonsteroidals, which had little impact. After diagnosis of a plasma cell population in the uid, we o ered local treatment with radiation and systemic treatment of multiple myeloma, which o ered better but suboptimal control. Possible treatments for olecranon bursitis include surgery, corticosteroid injections, anti-in ammatories, and serial drainage. Nonsurgical management may be more e ective 15 We combined conservative measures as well as treatment of the underlying disease, but we believe that our patient did not derive signi cant bene t because of the refractory nature of his disease; he also expressed a preference to avoid surgical intervention.
Conclusion
Bursitis is a rare but thought-provoking potential manifestation of multiple myeloma and AL amyloidosis; we believe that our patient's bursitis was related to plasma cell neoplasia based upon co-occurrence with disease relapse. His bursitis turned out to be an early indicator of impending systemic relapse. In this particular case, in which the patient wished to avoid surgical intervention, ow cytometry was of great value, and we believe that our case is the rst report of malignant bursitis being diagnosed by ow cytometry. Our patient's case shares similarities with other biopsy-con rmed cases of malignant bursitis, but we were able to avoid the need for surgical biopsy or bursal stripping.
